Funder: Dept. of the Army -- USAMRAA
Due Dates: July 23, 2026: Pre-Application (Letter of Intent) | August 6, 2026: Full Application | August 13, 2026: End of Application Verification Period
Funding Amounts: ~$3.5M total; up to $1.6M (single PI) or $1.9M (partnering PI option) for up to 3 years; ~2 awards expected
Summary: Funds clinical and translational research to advance diagnosis, prognosis, or treatment of tuberous sclerosis complex (TSC) toward clinical application.
Key Information: Multiple PIs allowed; pre-application required; open to domestic and foreign, public or private, for-profit or nonprofit entities.